Literature DB >> 9518954

Management of hospitalized patients with type 2 diabetes mellitus.

S H Lilley1, G I Levine.   

Abstract

Subopitmal glycemic control in hospitalized patients with type 2 (non-insulin-dependent) diabetes mellitus can have adverse consequences, including increased neurologic ischemia, delayed wound healing and an increased infection rate. Poor glycemic control can also affect the outcome of the primary illness. If possible, hospitalized diabetic patients should continue their previous antihyperglycemic treatment regimen. Decreased physical activity and the stress of illness often lead to hyperglycemia in hospitalized patients with type 2 diabetes. When indicated, insulin is given either as a supplement to usual therapy or as a temporary substitute. The overall benefit of the traditional sliding-scale insulin regimen has been questioned. Insulin supplementation given according to an algorithm may be a logical alternative. Any antihyperglycemic regimen should be administered and monitored in a manner coincident with the intake of food or other sources of calories. Factors that can alter glycemic control acutely, including specific medical conditions and medications, should be identified and anticipated.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9518954

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  4 in total

1.  Use of a standardized protocol to decrease medication errors and adverse events related to sliding scale insulin.

Authors:  A C Donihi; M M DiNardo; M A DeVita; M T Korytkowski
Journal:  Qual Saf Health Care       Date:  2006-04

2.  Diabetes management and self-care education for hospitalized patients with cancer.

Authors:  Ashley Leak; Ellen D Davis; Laura B Houchin; Melanie Mabrey
Journal:  Clin J Oncol Nurs       Date:  2009-04       Impact factor: 1.027

3.  Glycemic control in medical inpatients with type 2 diabetes mellitus receiving sliding scale insulin regimens versus routine diabetes medications: a multicenter randomized controlled trial.

Authors:  Lori M Dickerson; Xiaobu Ye; Jonathan L Sack; William J Hueston
Journal:  Ann Fam Med       Date:  2003 May-Jun       Impact factor: 5.166

Review 4.  The Financial Impact of an Inpatient Diabetes Management Service.

Authors:  Waqas Zia Haque; Andrew Paul Demidowich; Aniket Sidhaye; Sherita Hill Golden; Mihail Zilbermint
Journal:  Curr Diab Rep       Date:  2021-01-15       Impact factor: 4.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.